anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 75,361-75,390
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

75,361-75,390 of 96,741

filter-aware
29
Uses patient testimonials as primary evidence to challenge the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
30
The slide uses direct quotes from Facebook groups to undermine the product's safety/efficacy narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
32
The slide uses social media engagement (comment counts) as a proxy for negative sentiment and community concern.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
33
Uses a CEO quote to highlight a potential contradiction between management narrative and market reality.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
34
The slide uses a screenshot of a Soleno clinical trial flow diagram to highlight patient drop-off.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
35
The slide uses a Q&A transcript format to build a narrative of a cover-up regarding drug safety.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
36
The slide uses a Q&A format to highlight potential corporate malfeasance regarding clinical trial safety reporting.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
37
The slide uses a 'villain' narrative by framing patient advocacy groups as manipulators of the regulatory process.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
39
The slide uses a red box to highlight a specific time period in the C602-RWP study to question the validity of the efficacy results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
40
The slide uses a combination of narrative summary and direct Q&A transcript excerpts to build a case of potential clinical trial misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
41
The slide uses a 'villain' framing to question the validity of Soleno Therapeutics' clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
42
The slide uses a Q&A format to highlight internal skepticism regarding clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
43
The slide uses a 'quote-highlight' structure to emphasize specific allegations of misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
44
The slide uses a Q&A format to present whistleblower testimony.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
45
The slide uses strong, accusatory language ('hoax', 'scientifically unfounded', 'misleading') to attack the target company's scientific rationale.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
46
The slide uses a causal chain argument to refute a competitor's (Soleno) mechanism of action.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
47
The slide uses screenshots of social media posts as primary evidence to challenge the clinical narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
48
The slide uses a specific chart from a clinical paper to challenge the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
49
Uses a red-annotated chart to highlight the discrepancy between reported LBM and suspected fluid retention.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
52
The slide uses a 'smoking gun' narrative to allege data fabrication by comparing two sets of longitudinal clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
53
Soleno Therapeutics (SLNO)Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
54
The slide emphasizes the credibility of the interviewees by linking them to specific published papers (C601 and C602).Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
55
The slide uses a 'villain_critique' approach by leveraging an expert's authority to discredit the company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
56
The slide uses direct quotes from an expert to highlight risks of cardiac events, seizures, and trial design flaws.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
57
The slide uses direct quotes from an expert to undermine the viability of the company's drug formulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
59
Soleno Therapeutics (SLNO)Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
60
The slide uses direct quotes from an expert to discredit a competitor's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
61
This slide presents expert testimony/critique from a trial investigator, serving as a 'villain_critique' or 'expose_contradiction' style slide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
62
The slide uses a 'nominee_bio' structure to present a 'villain_critique' or 'expose_contradiction' narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
63
The slide uses direct quotes to expose potential data omissions and competitive disadvantage.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit